Author:
Goyette Bailey N,Hudnall Matthew T,Halpern Joshua A
Publisher
Springer Science and Business Media LLC
Subject
Urology,Obstetrics and Gynecology
Reference91 articles.
1. Malik RD, Wang CE, Lapin B, Lakeman JC, Helfand BT. Characteristics of men undergoing testosterone replacement therapy and adherence to follow-up recommendations in metropolitan multicenter health care system. Urology. 2015;85:1382–8.
2. Malik RD, Lapin B, Wang CE, Lakeman JC, Helfand BT. Are we testing appropriately for low testosterone?: characterization of tested men and compliance with current guidelines. J Sex Med. 2015;12:66–75.
3. Baillargeon J, Urban RJ, Kuo Y-F, Holmes HM, Raji MA, Morgentaler A, Howrey BT, Lin Y-L, Ottenbacher KJ (2015) Screening and monitoring in men prescribed testosterone therapy in the U.S., 2001-2010. Public Health Rep Wash DC 1974 130:143–152
4. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200:423–32.
5. Center for Drug Evaluation and Research Drug Safety and Availability - FDA Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging; requires labeling change to inform of possible increased risk of heart attack and stroke with use. https://wayback.archive-it.org/7993/20170112031557/http://www.fda.gov/Drugs/DrugSafety/ucm436259.htm. Accessed 13 Aug 2021